Search - tctmd.com

Displaying 81 - 100 of 6129

Sort: Relevancy | Date

Presentation TCT 2025

Acute Clot Embolization from ECMO and/or Impella

Presenter: Michael Cyrus Siah

October 26, 2025

Presentation TCT 2025

Access Site Hemorrhage – Getting Control of the Bleeder

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Access Site Occlusion With Acute Limb Ischemia

Presenter: S. Jay Mathews

October 26, 2025

News Conference News TCT 2025

Left Distal Radial Access Doesn’t Reduce Radiation for Operators: DOSE

Caitlin E. Cox

October 25, 2025

Presentation TCT 2025

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Presenter: Gerald S. Werner

October 25, 2025

Presentation TCT 2025

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial

Presenter: Johan R. Bennett

October 25, 2025

Presentation TCT 2025

Time for Diagnostic Paradigm Shift from ST-Elevation/Non-ST-Elevation to Occlusive/Non-Occlusive Myocardial Infarction: The DIFOCCULT-3 Trial

Presenter: Emre Aslanger

October 25, 2025

Presentation TCT 2025

Coronary CT Physiology-Derived Virtual Stenting vs. Coronary Angiography for Revascularization Optimization: The CT-COMPASS Trial

Presenter: Kefei Dou

October 25, 2025

Presentation TCT 2025

AI-Guided Quantitative Plaque Evaluation From CT To Identify Patients With Future Myocardial Infarction or Death

Presenter: Alexander Van Rosendael

October 25, 2025

Presentation TCT 2025

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

Presenter: Sheldon E. Litwin

October 25, 2025

Presentation TCT 2025

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

Presenter: Daniel Burkhoff

October 25, 2025

Presentation TCT 2025

ARS 14: AI-Enhanced Interventions and the Need for Advanced Interventional Therapies

Presenter: Jessica L. Mega

October 25, 2025

Presentation TCT 2025

Interatrial Shunting: A Critical View of The Field and Future Needs

Presenter: Sheldon E. Litwin

October 25, 2025

Presentation TCT 2025

New and Emerging Therapies in Interventional HF: Trials, Devices, and Strategies

Presenter: Nicole Dellise

October 25, 2025

Presentation TCT 2025

ARS 28: Inter-Atrial Shunts and HF Treatment

Presenter: Daniel Burkhoff

October 25, 2025

Presentation TCT 2025

Pacing and Functional Valve Disease: Mechanisms & Management of MR, TR, and Heart Failure

Presenter: Josip Katinic

October 25, 2025

Presentation TCT 2025

From Hemodynamic Support to Heart Transplant: Current Trends and Future Perspectives

Presenter: Jesus Eduardo Rame

October 25, 2025

Presentation TCT 2025

ARS 27: Hemodynamic Support in HF Treatment

Presenter: Daniel Burkhoff

October 25, 2025

Presentation TCT 2025

Timing the Transition: Hemodynamic Decompensation and MCS Candidacy in Heart Failure

Presenter: Cate Enstrom

October 25, 2025

Presentation TCT 2025

Valvular Dysfunction and Heart Failure: Hemodynamic Insights into AS, AI, MR, and TR

Presenter: Michael I. Brener

October 25, 2025

Advertisement

Acute Clot Embolization from ECMO and/or Impella

Access Site Hemorrhage – Getting Control of the Bleeder

Access Site Occlusion With Acute Limb Ischemia

Left Distal Radial Access Doesn’t Reduce Radiation for Operators: DOSE

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial

Time for Diagnostic Paradigm Shift from ST-Elevation/Non-ST-Elevation to Occlusive/Non-Occlusive Myocardial Infarction: The DIFOCCULT-3 Trial

Coronary CT Physiology-Derived Virtual Stenting vs. Coronary Angiography for Revascularization Optimization: The CT-COMPASS Trial

AI-Guided Quantitative Plaque Evaluation From CT To Identify Patients With Future Myocardial Infarction or Death

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

ARS 14: AI-Enhanced Interventions and the Need for Advanced Interventional Therapies

Interatrial Shunting: A Critical View of The Field and Future Needs

New and Emerging Therapies in Interventional HF: Trials, Devices, and Strategies

ARS 28: Inter-Atrial Shunts and HF Treatment

Pacing and Functional Valve Disease: Mechanisms & Management of MR, TR, and Heart Failure

From Hemodynamic Support to Heart Transplant: Current Trends and Future Perspectives

ARS 27: Hemodynamic Support in HF Treatment

Timing the Transition: Hemodynamic Decompensation and MCS Candidacy in Heart Failure

Valvular Dysfunction and Heart Failure: Hemodynamic Insights into AS, AI, MR, and TR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content